Rexahn Pharmaceuticals, Inc. (RNN.A) Company Profile | Stocks | Reuters.com
Read the Rexahn Pharmaceuticals, Inc. RNN.A company profile at Reuters.com. ... Archexin is in Phase II trials for treatment of renal cell carcinoma (RCC) and ...Summary of REXAHN PHARMACEUTICALS, INC. - Yahoo! Finance
These fees are to be used in the cooperative funding of the costs of development of Archexin ... II clinical trial of Archexin_ began in the third quarter ...Summary of REXAHN PHARMACEUTICALS, INC. - Yahoo! Finance
The Phase II clinical trial of Archexin is expected to begin this year in ... The trial is the first of multiple trials planned for Archexin. ...Rexahn Pharmaceuticals, Inc. (RNN) Initiates Phase II Pancreatic Cancer ...
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a leader in development of innovative therapeutics for life ... Archexin is a first-in-class, potent ...